Mannatech's Dr. Stephen Boyd Joins Distinguished Lineup at London Conference

COPPELL, Texas, Jan. 10 /PRNewswire-FirstCall/ -- Add the U.K. to Dr. Stephen Boyd's whirlwind January speaking schedule.

Mannatech's (Nasdaq: MTEX) Medical Director, Health Services is scheduled to join a distinguished lineup of speakers at the Nutraceuticals, Foods and Probiotics 2003 conference to be held at The Hatton in London, England Jan. 15-16. Dr. Boyd is currently touring Canada in support of the Canadian launch of Mannatech's GlycoLEAN(R) Body System.

Dr. Boyd will join speakers from Nestle, GlaxoSmithKline, Roche-Vitamins and the International Food Information Council. Conference topics are scheduled to include a focus on regulatory matters, marketing challenges, recent developments in probiotics and the value of functional foods.

"This is a wonderful opportunity to meet with others in the field and compare notes," said Dr. Boyd. "It is important for Mannatech to be
represented at events of this nature. It solidifies our position as one of the industry leaders."

Dr. Boyd's appearance at the conference returns him to the city where he received one of his highest honors. In April 2001, at the general meeting in London, Dr. Boyd was elected a Fellow of The Royal Society of Medicine (FRSM). He also holds BS and PhD degrees in Chemistry at the University of Glasgow, Scotland and an MD degree from the University of Toronto. He joined Mannatech in 1997.

Mannatech, Inc. is a wellness solution provider that develops innovative, high-quality, proprietary nutritional supplements, topical products and weight management products, which are sold through a global network-marketing system throughout the United States and the international markets of Canada, Australia, the United Kingdom, Japan and New Zealand.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.